usps-logo.jpg?1721728722
Ultrafast Ultrasonic Synthesis
Catalog peptides: immediate delivery
ISO 9001/2015 certified
1000 peptides & peptide pools
30 years of experience in peptide synthesis

VP1 372-380 (HLA-B*07:02)
( VPQYGYLTL )



This peptide is the capsid derived immunodominant adeno-associated virus 2 (AAV2), CD8 T cell epitope. Liver toxicity observed in a clinical trial of AAV2 delivered systemically to patients with hemophilia was ascribed to killing of vector-transduced hepatocytes by capsid-specific T-cells. VPQYGYLTL is a linear peptidic epitope (epitope ID70458) studied as part of Capsid protein VP1 from Adeno-associated dependoparvovirus A. This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assaysThis peptide is the capsid derived immunodominant adeno-associated virus 2 (AAV2), CD8 T cell epitope. Liver toxicity observed in a clinical trial of AAV2 delivered systemically to patients with hemophilia was ascribed to killing of vector-transduced hepatocytes by capsid-specific T-cells. VPQYGYLTL is a linear peptidic epitope (epitope ID70458) studied as part of Capsid protein VP1 from Adeno-associated dependoparvovirus A. This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assaysThis peptide is the capsid derived immunodominant adeno-associated virus 2 (AAV2), CD8 T cell epitope. Liver toxicity observed in a clinical trial of AAV2 delivered systemically to patients with hemophilia was ascribed to killing of vector-transduced hepatocytes by capsid-specific T-cells. VPQYGYLTL is a linear peptidic epitope (epitope ID70458) studied as part of Capsid protein VP1 from Adeno-associated dependoparvovirus A. This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assaysThis peptide is the capsid derived immunodominant adeno-associated virus 2 (AAV2), CD8 T cell epitope. Liver toxicity observed in a clinical trial of AAV2 delivered systemically to patients with hemophilia was ascribed to killing of vector-transduced hepatocytes by capsid-specific T-cells. VPQYGYLTL is a linear peptidic epitope (epitope ID70458) studied as part of Capsid protein VP1 from Adeno-associated dependoparvovirus A. This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assaysThis peptide is the capsid derived immunodominant adeno-associated virus 2 (AAV2), CD8 T cell epitope. Liver toxicity observed in a clinical trial of AAV2 delivered systemically to patients with hemophilia was ascribed to killing of vector-transduced hepatocytes by capsid-specific T-cells. VPQYGYLTL is a linear peptidic epitope (epitope ID70458) studied as part of Capsid protein VP1 from Adeno-associated dependoparvovirus A. This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assaysThis peptide is the capsid derived immunodominant adeno-associated virus 2 (AAV2), CD8 T cell epitope. Liver toxicity observed in a clinical trial of AAV2 delivered systemically to patients with hemophilia was ascribed to killing of vector-transduced hepatocytes by capsid-specific T-cells. VPQYGYLTL is a linear peptidic epitope (epitope ID70458) studied as part of Capsid protein VP1 from Adeno-associated dependoparvovirus A. This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assaysThis peptide is the capsid derived immunodominant adeno-associated virus 2 (AAV2), CD8 T cell epitope. Liver toxicity observed in a clinical trial of AAV2 delivered systemically to patients with hemophilia was ascribed to killing of vector-transduced hepatocytes by capsid-specific T-cells. VPQYGYLTL is a linear peptidic epitope (epitope ID70458) studied as part of Capsid protein VP1 from Adeno-associated dependoparvovirus A. This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assaysThis peptide is the capsid derived immunodominant adeno-associated virus 2 (AAV2), CD8 T cell epitope. Liver toxicity observed in a clinical trial of AAV2 delivered systemically to patients with hemophilia was ascribed to killing of vector-transduced hepatocytes by capsid-specific T-cells. VPQYGYLTL is a linear peptidic epitope (epitope ID70458) studied as part of Capsid protein VP1 from Adeno-associated dependoparvovirus A. This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays

Sequence:VPQYGYLTL
Gene:VP1
Delivery: 3 weeks
C-Terminus:OH
N-Terminus:H
Amount:1 mg
Counter Ion:TFA
Protein:Major capsid protein VP1
Species:(HBoV1) (Human bocavirus type 1)
Allele:HLA-B*07:02
Application :T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response
Indication :Cancer;Gene therapy
Purity :95% HPLC-MS
Special references for this product will come soon.
For your convenience, we have compiled a selection of publications
where our peptide products have been employed:
Publications >

€60.40*

Delivery time 2-3 days
sterile and endotoxin free
Delivery Format: The product is supplied freeze dried.
Purity: 95% HPLC-MS
Amount in mg
Product number: EP11463_1